NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $36,000 | -16.3% | 11,246 | 0.0% | 0.00% | – |
| Q2 2022 | $43,000 | -29.5% | 11,246 | 0.0% | 0.00% | – |
| Q1 2022 | $61,000 | -59.9% | 11,246 | 0.0% | 0.00% | – |
| Q4 2021 | $152,000 | -24.8% | 11,246 | 0.0% | 0.00% | – |
| Q3 2021 | $202,000 | +4.7% | 11,246 | 0.0% | 0.00% | – |
| Q2 2021 | $193,000 | -14.2% | 11,246 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $225,000 | +17.8% | 11,246 | 0.0% | 0.00% | – |
| Q4 2020 | $191,000 | +2.7% | 11,246 | 0.0% | 0.00% | – |
| Q3 2020 | $186,000 | -28.7% | 11,246 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $261,000 | +29.9% | 11,246 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $201,000 | -17.3% | 11,246 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $243,000 | -79.9% | 11,246 | -83.1% | 0.00% | -66.7% |
| Q3 2019 | $1,210,000 | -77.4% | 66,434 | -55.8% | 0.00% | -75.0% |
| Q2 2019 | $5,354,000 | -25.6% | 150,381 | -29.8% | 0.01% | -25.0% |
| Q1 2019 | $7,198,000 | -3.3% | 214,121 | -4.6% | 0.02% | -11.1% |
| Q4 2018 | $7,444,000 | -24.6% | 224,415 | +38.5% | 0.02% | 0.0% |
| Q3 2018 | $9,876,000 | +312.9% | 162,011 | +230.8% | 0.02% | +260.0% |
| Q2 2018 | $2,392,000 | -43.4% | 48,982 | +23.1% | 0.01% | -37.5% |
| Q1 2018 | $4,229,000 | +396.9% | 39,805 | +179.4% | 0.01% | +300.0% |
| Q4 2017 | $851,000 | +66.9% | 14,246 | -32.9% | 0.00% | +100.0% |
| Q3 2017 | $510,000 | – | 21,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |